| Literature DB >> 10597748 |
M Ozgüroglu1, H Turna, G Demir, A Döventas, F Demirelli, N M Mandel, E Büyükünal, S Serdengeçti, B Berkarda.
Abstract
CA-125, a commonly used tumor marker for epithelial ovarian cancer, is a glycoprotein found in normal tissues derived from coelomic epithelia. Increased serum levels of CA-125 have also been found in nongynecologic tumors and nonmalignant diseases involving the peritoneum. A few recent studies and sporadic case reports have reported increased CA-125 levels in patients with non-Hodgkin's lymphoma (NHL). In our study, we aimed to evaluate the serum levels of CA-125 in patients with NHL and determine its potential role to show disease activity in NHL. Serum levels of CA-125 were measured in 61 patients with NHL and were found to be correlated with clinical stage, site of involvement, and disease activity.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10597748 DOI: 10.1097/00000421-199912000-00014
Source DB: PubMed Journal: Am J Clin Oncol ISSN: 0277-3732 Impact factor: 2.339